MedPath

Efficacy Ezetimibe for dyslipidemia: A prospective cohort study

Phase 4
Conditions
Dyslipidemia during statin treatment
Registration Number
JPRN-UMIN000037604
Lead Sponsor
Sekino Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who were deemed not appropriate to participate in this study by doctor

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
D
Secondary Outcome Measures
NameTimeMethod
1) HDL, T-cho, TG 2) BUN, Cr, AST, ALT, CK, HbA1c 3) cystatin C, oxidized LDL, fatty acid fractionation, Lp (a), 4) Lipo fractionation, remnant-Like Particle 5) FMD, carotid echo, ABI 6) Cardiovascular events
© Copyright 2025. All Rights Reserved by MedPath